Kronos Bio Highlights Preclinical Data At AACR Symposium Supporting Istisociclib Clinical Evaluation In Advanced Ovarian Cancer, Showing Efficacy In Platinum And PARP-Inhibitor Resistant Models
Kronos Bio Highlights Preclinical Data At AACR Symposium Supporting Istisociclib Clinical Evaluation In Advanced Ovarian Cancer, Showing Efficacy In Platinum And PARP-Inhibitor Resistant Models
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.